NewStem vs Tamarix
NewStem vs Tamarix, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: NewStem is on 45/100 and Tamarix on 44/100.
Where each one leads
NewStem
- funding raised: $30.0M against $15.0M
Tamarix
Leads on none of the measures we hold for both companies.
At a glance
| Measure | NewStem | Tamarix |
|---|---|---|
| What it is | Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy. | Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases. |
| Category | Life Sciences, Biotech, Biopharmaceutical, MedTech | Life Sciences, Biopharmaceutical, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2018 | 2020 |
| Headquarters | Rehovot, Israel | San Diego, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | NewStem | Tamarix |
|---|---|---|
| Employees | Not published | 2 |
| Total funding | $30.0M | $15.0M |
| Latest round | Series B | Seed |
| LinkedIn followers | Not published | 13 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | NewStem | Tamarix |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 44/100 |
| Traction | 37/100 | 41/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 9/100 | 16/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 4/100 | Not published |
NewStem vs Tamarix: common questions
Which is better, NewStem or Tamarix?
On our 0-100 score NewStem rates higher (45/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do NewStem and Tamarix compare on the numbers?
NewStem leads on funding raised ($30.0M against $15.0M).
Read the full NewStem review and pricing or the Tamarix review and pricing. You can also browse other NewStem alternatives we track.